OliX PharmaceuticalsInc Cash Flow Quality Index

Latest as of December 2025: -0.79x

OliX PharmaceuticalsInc cash flow quality index. OliX PharmaceuticalsInc (226950) has a Cash Flow Quality Index of -0.79x as of December 2025. Operating cash flow of ₩-12.16 Billion is below net income of ₩15.39 Billion, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of OliX PharmaceuticalsInc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.79x
Operating CF / Net Income

Operating Cash Flow

₩-12.16 Billion
KRW

Net Income

₩15.39 Billion
KRW

Data as of

Dec 2025
Most recent filing

OliX PharmaceuticalsInc Cash Flow Quality Index by Year (None–None)

OliX PharmaceuticalsInc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for OliX PharmaceuticalsInc. For the full cash flow conversion analysis, see OliX PharmaceuticalsInc operating cash flow efficiency.

Year Quality Index Operating CF (KRW) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.